Mesalamine Suppository
Product Images NDC 70771-1513

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 70771-1513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister Label (Fea66d66 0735 4917 Ba39 D9e02a894717 02)

Mesalamine Suppository 1000 mg rectal use packaging label by Zydus Lifesciences Limited. The label shows six individual suppository units with the front displaying the product name, strength, and route, and the back listing the NDC 70771-1513 and storage instructions to keep below 25°C (77°F). The label indicates the product is made in India.*

FDA Label Image

Carton Label (Fea66d66 0735 4917 Ba39 D9e02a894717 03)

Packaging label for Mesalamine Suppositories 1000 mg by Zydus Lifesciences Limited. The label indicates the medication is for rectal use only, presented in a 30 suppositories count box. The label includes the product name, strength, dosage form, and usage route, with barcode and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.